SN
Sona Nanotech Inc.
SNANF · OTC
$0.26 +0.00% (+$0.00)
1M +7.28%
Market Cap $41.9M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.18
30.8% downside
Current Price
$0.26
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SNANF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 781.70%
ROA 365.18%
Debt
0 /100
High Int. coverage -68.84x
Current ratio 0.07x
Debt/Assets N/A
Stability
76 /100
Stable Profitable years 0
Beta 0.99x
EPS volatility 11.62%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SNANF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Andrew Regan
Employees
8
Headquarters
Halifax